The persistence of dextran in the circulation after its intravenous injection depends upon the molecular-weight distribution ; smaller molecules are quickly excreted, while larger ones stay and maintain the plasma volume. As molecular weight increases the interaction of dextran molecules with proteins and cells increases. Allergic reactions and increases in bleeding-time have been ascribed to the larger molecules. Moreover, dextran molecules large enough to remain in the circulation for what may be considered to be a useful time tend to cause red cells to adhere together, forming rouleaux.
The dextran used in this country, dextran B.P., has a higher average molecular weight (150,000) than is advocated elsewhere. This confers the advantage of ensuring a satisfactorily long duration of plasma-volume expansion, but it does carry with it the disadvantages referred to in the previous paragraph. Whether or not increased aggregation of red cells is a serious disadvantage remains undecided after 10 years or more of using this dextran.
In the past few years, however, observations of blood-flow in animals have underlined the possible ill effects (Gelin and Zederfeldt, 1961) of high concentrations of dextran of high molecular weight upon the free flow of blood in capillaries through excessive rouleaux formation (Thorsen and Hint, 1950) . Microcirculatory and histological investigations have been made on the aggregation of red cells by dextrans (Stalker, 1961 (Stalker, , 1964 . " Sludging " of the blood and blocking of capillaries have been observed and recorded on cine-film in rabbits, both normal and shocked, which had been given dextran B.P., but these effects occurred to a much less degree after infusion of the dextrans of lower average molecular weight used elsewhere. The is a steeply increasing effect with increasing intrinsic viscosity. " K" was defined as the corrected maximum sedimentation velocity at 1 % dextran concentration measured under standardized conditions. It was also shown that the effects of mixtures of dextran fractions on red-cell sedimentation were in proportion to the amount of each fraction present (Hardwicke and Squire, 1952) .
Consider now a sample of dextran B.P. which has been fractionated into 14 fractions (Rowe, 1956) . Table I shows the percentage by weight of each fraction and the inherent viscosity of each fraction (for the purpose of this discussion inherent viscosity may be assumed to be identical with intrinsic viscosity). The fourth column of the Table shows Inherent viscosity closely approximates to intrinsic viscosity but is calculated from a measurement of relative viscosity at one concentration. The inherent viscosity of the whole is 0-31, of fractions 5 to 14 it is 0-28, and of fractions 5 + 6-i.e., the top 14% of fractions 5 to 14-st is 0 34.
The effect of fractioning the dextran to any desired extent may now be seen. For instance, it is possible to remove in one step the first four fractions, which total some 28% by weight, thus removing those molecules which make the greatest contribution, probably more than 50%, to red-cell aggregation. The corresponding changes in intrinsic viscosity have been calculated and are shown in Table I . The persistence in the human circulation of dextrans of various molecular weights was measured by Howard et al. (1956) , who found little difference between fractions of average molecular weight 194,000, 255,000, and 412,000. The top 30% of dextran B.P. includes material with these molecular weights. There is therefore reason to believe that sludging could be minimized by removing approximately 30% from the upper end of the molecular-weight range of dextran B.P. without greatly affecting its persistence in the circulation. Table II . As might be expected, it proved difficult to reduce the average molecular weight without at the same time exceeding the 25 % limit for renal excretion laid down by the B.P.; nevertheless, the technical difficulties of fractionation on a large scale were satisfactorily overcome. Except in respect of molecular size the solutions of modified dextran conformed to the B.P. specification.
Simple experiments in vitro showed that the effect of the modified dextrans upon red-cell sedimentation rate was substantially less than that of the dextran B.P. in current use (see Fig. 2 A search for histological damage to lung, kidney, adrenal, liver, and myocardium was made in 10 rabbits subjected to haemoconcentration by subcutaneous infiltration under anaesthesia of 40 ml. of 50% dextrose. All were in moderate shock after two hours, and were given 20 ml. modified dextran solution per kg. body weight. They were killed after 48 hours. Slight histological changes (trivial round-cell infiltration or focal necrosis) were observed in the myocardium and liver in about half the animals. These changes were notably less in incidence and degree than those observed after transfusion of dextran B.P.
The persistence in the circulation and the magnitude and duration of plasma-volume expansion were measured in an experiment of cross-over design in rabbits. The performance of the two modified dextrans was compared with that of two B.P. dextrans. Four rabbits were used, each receiving a modified dextran, followed after a suitable interval by a B.P. dextran or vice versa, Before each measurement "25I-labelled rabbit albumin was allowed to equilibrate in the animal, and changes in plasma volume were deduced from changes in plasma radioactivity. Results were averaged for the modified and for the B.P. dextrans, thereby minimizing rabbit-to-rabbit and other experimental differences. The modified dextran appeared to leave the circulation a little more quickly than dextran B.P. (see Fig. 3 ). The magnitude and duration of plasma-volume expansion are shown in Fig. 4 ; the original plasma volume of the rabbits was about 110 ml., and this is shown as 100% on the graph. The initial expansion was slightly more than the volume injected, and some degree of expansion lasted for two or three days for both the modified and the B.P. dextrans. Differences between the dextrans are probably not significant owing to the limited accuracy of this kind of experiment.
The viscosity measurements confirmed that the modified dextran contained less material of high molecular weight. The effects of this modification were measurable in vitro as a reduction of red-cell sedimentation rate and observable in vivo in the capillary blood circulation of the rabbit's ear. Persistence of dextran in circulation, the proportion subject to renal excretion, and the magnitude and duration of plasma-volume expansion were substantially unaltered. There was therefore reason to believe that the modified dextran represented an improvement on the currently used dextran B.P.
Clinical Trial
Before recommending an alteration in the molecular-weight distribution it seemed desirable that dextran solutions with the proposed new composition should be used by clinicians with previous experience of dextran under conditions of careful observation. The purposes of this trial were: (1) to collect opinions on the effectiveness, judged clinically, of the solutions as plasma-volume expanders; (2) to measure the amount of dextran in blood and urine at various times after transfusion; (3) to observe whether transfusion of these solutions causes any difficulty in blood grouping and cross-matching of subsequently collected blood samples.
An important use of plasma and therefore of plasma substitutes is in the treatment of burned patients. Some of the new dextran was used in the treatment of burned patients at Queen Mary's Hospital, Roehampton, where dextran has been in regular use for many years. The new dextran was also used in the Bums Unit of Birmingham Accident Hospital, where freeze-dried plasma is generally used; here the volume of dextran transfused was limited to the supposed normal plasma volume of the patients, and any further colloid required was provided as plasma. Table III summarizes the age of the patients, the area burned, and the colloid transfusions given. Cases 1 to 3 were at Roehampton, the others were in Birmingham. In addition to those listed in Table III The effectiveness of a plasma-volume expander is not easy to judge clinically. Surgeons were asked if the expansion of plasma volume had appeared adequate, and whether the expansion had lasted long enough. Unequivocal replies in the affirmative to both of these questions were given in respect of Cases 1 to 3. In Cases 4 to 9, in which plasma was given immediately after dextran, any deficiency of the dextran would be more difficult to detect; the clinical response as regards the haematocrit reading, urinary output, and general condition of the patient was considered satisfactory by the surgeons. Fig. 5 In carrying out blood-grouping tests or cross-matching tests on blood containing dextran there are no problems provided that red cells which have been exposed to dextran-containing serum are first washed. For example, if the indirect antiglobulin test is used for cross-matching donor's red cells against the serum of a patient who has received dextran B.P. no problems are encountered (Bull et al., 1949) . When agglutination tests are used, as when saline suspensions of red cells are incubated with serum from a patient, excessive rouleaux formation may cause difficulties ; suspension of red cells in concentrated albumin rather than saline greatly diminishes the rouleaux formation (Marston, 1954) . In the present series the two sera with the highest dextran concentrations (2.33 and 2.86 g./ 100 mnl). could not be cross-matched satisfactorily without albumin. All other samples could be cross-matched satisfactorily in saline, either at room temperature or at 370 C. 
Summary

